Product Added Successfully.Please click cart button to proceed
Uploaded Successfully
Thank you for choosing TimesMed Pharmacy
Our representatives will contact you as soon as possible. If you want to reach us immediately, please call 98 8455 5001
Neored Eye Drop
PRODUCT DETAILS
About Neored Eye Drop
Naphazoline + Phenylephrine + Carboxymethylcellulose is a combination of two medicines: Naphazoline, phenylephrine and carboxymethylcellulose.
Uses of Neored Eye Drop
Naphazoline+Phenylephrine+Carboxymethylcellulose is used in the treatment of allergic eye disease.
Medicinal Benefits of Neored Eye Drop
Naphazoline is a sympathomimetic-alpha 1 medicine which narrows the blood vessels in the eye, thereby reducing redness and swelling. Phenylephrine is a decongestant which works by narrowing blood vessels of the eye to relieve inflammation. Carboxymethylcellulose is a lubricating formulation similar to natural tears. It provides temporary relief of burning and discomfort due to dryness of the eye.
Directions for Use
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Side Effects of Neored Eye Drop
Eye irritation, Eye pain, Stinging in the eyes, Blurred vision, Photophobia
Similar Drugs
For informational purposes only. Consult a doctor before taking any medicines.
Safety Advice
PREGNANCY
Please consult your doctor if you have any concerns regarding this, your doctor will prescribe only if the benefits outweigh the risks.
BREAST FEEDING
Consult your doctor before taking Naphazoline + Phenylephrine + Carboxymethylcellulose ; your doctor will decide whether Naphazoline + Phenylephrine + Carboxymethylcellulose can be taken by breastfeeding mothers or not.
LIVER
Please consult your doctor if you have a liver impairment or any concerns regarding this.
KIDNEY
Please consult your doctor if you have kidney impairment or any concerns regarding this.